Edition:
United States

Align Technology Inc (ALGN.OQ)

ALGN.OQ on NASDAQ Stock Exchange Global Select Market

215.57USD
14 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$215.57
Open
$214.27
Day's High
$217.34
Day's Low
$212.24
Volume
362,383
Avg. Vol
414,292
52-wk High
$398.46
52-wk Low
$188.57

Summary

Name Age Since Current Position

Charles Larkin

69 2006 Independent Chairman of the Board

Joseph Hogan

61 2015 President, Chief Executive Officer, Director

John Morici

51 2016 Chief Financial Officer and Senior Vice President, Global Finance

Zelko Relic

53 2018 Chief Technology Officer and Senior Vice President, Global Research & Development

Simon Beard

51 2015 Senior Vice President and Managing Director, EMEA

Jennifer Olson

40 2018 Senior Vice President and Managing Director, Doctor Directed Consumer Channel

Julie Tay

51 2018 Senior Vice President and Managing Director, Asia Pacific

Stuart Hockridge

46 2018 Senior Vice President of Global Human Resources

Roger George

52 2018 Senior Vice President, Chief Legal and Regulatory Officer

Sreelakshmi Kolli

43 2018 Senior Vice President, Global Information Technology

Emory Wright

48 2018 Senior Vice President, Global Operations

Brad Jergenson

2018 Vice President and General Manager - United States

Sian Roberts

2017 Vice President and General Manager - of Canada

Raphael Pascaud

46 2018 Chief Marketing Portfolio and Business Development Officer, and Senior Vice President iTero Scanner and Services

Thomas Prescott

62 2015 Director

Kevin Dallas

54 2018 Independent Director

Joseph Lacob

62 1997 Independent Director

George Morrow

66 2006 Independent Director

Andrea Saia

60 2013 Independent Director

Gregory Santora

66 2003 Independent Director

Susan Siegel

57 2017 Independent Director

Warren Thaler

55 2004 Independent Director

Shirley Stacy

Corporate and Investor Relations Contact

Biographies

Name Description

Charles Larkin

Mr. Charles Raymond Larkin (Ray) Jr. is Independent Chairman of the Board of the Company. He currently is a Principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. From 2001 to 2007, he served as a part time Venture Partner at Cutlass Capital, a venture capital firm. Mr. Larkin was previously Chairman and Chief Executive Officer at Eunoe, Inc., a medical device company. From 1983 to March 1998, he held various executive positions with Nellcor Puritan Bennett, Inc., a medical instrumentation company, for which he served as President and Chief Executive Officer from 1989 until 1998. Mr. Larkin also held various positions of increasing responsibility at Bentley Laboratories/American Hospital Supply from 1976 to 1983. He serves on the board of directors of Heartware, Inc., a medical device company developing implant devices for the treatment of advanced heart failure. Mr. Larkin received his B.S. in Industrial Management from LaSalle University.

Joseph Hogan

Mr. Joseph M. Hogan is President, Chief Executive Officer, Director of the Company. Prior to joining us, Mr. Hogan was Chief Executive Officer of ABB Ltd., a global power and automation technologies company based in Zurich, Switzerland, from 2008 to 2013. Prior to ABB, Mr. Hogan worked at General Electric Company (GE) in a variety of executive and management roles from 1985 to 2008, including eight years as Chief Executive Officer of GE Healthcare from 2000 to 2008. Mr. Hogan earned a MSBA from Robert Morris University and a B.S. in Business Administration from Geneva College.

John Morici

Mr. John F. Morici is Chief Financial Officer and Senior Vice President, Global Finance of the Company. Prior to joining us, Mr. Morici was at NBC Universal from 2007 to 2016 where he held several senior management positions in their Universal Pictures Home Entertainment U.S. and Canadian business, including Chief Financial Officer, Chief Operating Officer, and most recently, Executive Vice President and Managing Director from 2014 to 2016. Prior to NBC Universal, Mr. Morici was in various senior financial management positions at GE Healthcare from 1999 to 2007, including Chief Financial Officer for its Diagnostic Imaging and Global Products units from 2002 to 2003.

Zelko Relic

Mr. Zelko Relic serves as Chief Technology Officer and Senior Vice President, Global Research & Development of the company. Prior to joining us, Mr. Relic was Vice President, Engineering for Datalogic Automation, a global leader in automatic data capture and industrial automation markets from 2012. Mr. Relic was previously Vice President, Engineering at Danaher Corporation, Accu-Sort Systems business from 2010 to 2012 before it was acquired by Datalogic Automation. From 2005 to 2010, he was at Siemens Medical Solutions USA, most recent as Vice President, and from 2002 to 2004, he held senior management positions in engineering at Kulicke & Soffa Industries, designers and manufactures of semiconductor products. He also held management positions at KLA-Tencor from 1994 to 2000.

Simon Beard

Mr. Simon Beard is Senior Vice President and Managing Director, EMEA of the company. In February 2018, Mr. Beard's title was changed to Senior Vice President and Managing Director, EMEA. Prior to joining us, from 2012 to 2014, Mr. Beard was Regional Director for the South East Asia business of Smith & Nephew, a multinational medical equipment manufacturing company. From 2006 to 2012, Mr. Beard was Director & General Manager for UK and Ireland for Smith & Nephew's Advanced Woundcare business. Prior to Smith & Nephew, Mr. Beard held multiple commercial, strategic, and general management positions in companies such as DePuy International (Johnson & Johnson), Sankyo Pharmaceutical and Sanofi Aventis.

Jennifer Olson

Ms. Jennifer Olson is Senior Vice President and Managing Director, Doctor Directed Consumer Channel of the Company. She joined us in 2002 and has held multiple roles in sales, marketing, and business development. Most recently, she was Area Sales Director for the North America region where she led all sales activities in Western Canada and the Western region of the U.S. Prior to joining Align, Ms. Olson was with technology companies including Extreme Networks and PWI Technologies.

Julie Tay

Ms. Julie Tay is Senior Vice President and Managing Director, Asia Pacific of the company. Prior to joining us, Ms. Tay was regional head of Bayer Healthcare (Diabetes Care) overseeing operations across Asia from 2010 to 2013. From 2006 to 2010, Ms. Tay served as director of marketing and corporate accounts at Sealed Air Corporation (formerly Johnson Diversey), a global provider of food safety and security, facility hygiene and product protection. Prior to that, Ms. Tay spent 15 years with Johnson & Johnson Medical.

Stuart Hockridge

Mr. Stuart Hockridge is Senior Vice President of Global Human Resources of the Company. Prior to joining us, Mr. Hockridge was Senior Vice President of Talent at Visa Inc. from 2013 to 2016 where he led all aspects of talent delivery for the company including executive development, succession planning, employee engagement, learning and development, and talent acquisition. Prior to Visa, Mr. Hockridge held a number of human resource management positions at GE Healthcare from 2002 to 2012 leading HR processes both globally and for various divisions.

Roger George

Mr. Roger E. George is Senior Vice President, Chief Legal and Regulatory Officer of the company. Prior to joining us, Mr. George was the Chief Financial Officer, Vice President of Finance and Legal Affairs and General Counsel of SkyStream Networks, a privately held broadband and broadcast network equipment company. Prior to SkyStream, Mr. George was a partner at Wilson Sonsini Goodrich & Rosati, P.C. in Palo Alto, California.

Sreelakshmi Kolli

Ms. Sreelakshmi Kolli is Senior Vice President, Global Information Technology of the Company. Ms. Kolli joined us in June 2003 and has held positions leading business operations and engineering for customer-facing applications. Before joining us, she held technical lead positions with Sword CT Space and Accenture.

Emory Wright

Mr. Emory M. Wright is Senior Vice President, Global Operations of the Company. He has been with us since March 2000 predominantly in manufacturing and operations roles including Vice President, Manufacturing and was General Manager of New Product Development. Prior to joining Align, from 1999 to 2000, Mr. Wright was Senior Manufacturing Manager at Metrika, Inc. a medical device manufacturer. Mr. Wright served as Manager of Manufacturing and Process Development for Metra Biosystems Inc.

Brad Jergenson

Mr. Brad Jergenson is Vice President and General Manager - United States of the Company. Mr. Jergenson brings more than 25 years of experience in the healthcare industry working in various leadership roles with a number of companies. He has spent the last 17 years with GE Healthcare where he held a number of positions including GM of Cardiology, VP and GM of Patient Monitoring, VP and GM of Commercial Operations, VP and GM for Commercial Operations for Life Sciences, Chief Marketing Officer and Senior VP of Sales and Marketing. Prior to GE, he worked for Johnson & Johnson and held numerous senior positions including commercial and marketing roles.

Sian Roberts

Ms. Sian Roberts is Vice President and General Manager - of Canada of the Company. Ms. Roberts has a broad range of leadership experience including strategy development and execution in both B2C and B2B markets. She has a passion for innovative technology in the healthcare space and has held several management positions in large global organizations. As the Canadian General Manager for Johnson & Johnson Vision Care (makers of ACUVUE® Brand Contact Lenses), Ms. Roberts led the organization through significant market shifts, growing the business across multiple channels. She also led the successful turnaround of Bausch & Lomb Canada after it was acquired by Valeant Pharmaceuticals. Since joining Align, Ms. Roberts has built out a Canadian commercial organization to localize strategy and investments to accelerate growth in Canada.

Raphael Pascaud

Mr. Raphael S. Pascaud is Chief Marketing Portfolio and Business Development Officer, and Senior Vice President iTero Scanner and Services of the company. He joined Align in 2010 as Vice President and Managing Director for EMEA and was promoted in January 2014 to Vice President, International. Prior to Align, Mr. Pascaud spent 14 years in various management positions within Johnson & Johnson, including Vice President Orthopedics of EMEA and Vice President Marketing of International.

Thomas Prescott

Mr. Thomas M. Prescott is Director of the Company. Prior to joining Align, Mr. Prescott was President and Chief Executive Officer of Cardiac Pathways, Inc. from May 1999 to August 2001 and a consultant for Boston Scientific Corporation from August 2001 to January 2002 after its acquisition of Cardiac Pathways in August 2001. Prior to Cardiac Pathways, Mr. Prescott held various sales, general management and executive roles at Nellcor Puritan Bennett, Inc. from April 1994 to May 1999, and various management positions at GE Medical Systems from October 1987 to April 1994. In addition, Mr. Prescott served in sales, marketing and management roles at Siemens AG from December 1980 to July 1986. He received his B.S. in Civil Engineering from Arizona State University and Masters in Management from Northwestern University. Mr. Prescott has served as a member of the Board since joining Align in 2002.

Kevin Dallas

Mr. Kevin J. Dallas has been appointed Independent Director of the Company effective on May 16, 2018. In his current role at Microsoft Corporation (NASDAQ: MSFT), Mr. Dallas is Corporate Vice President, Artificial Intelligence & Intelligent Cloud Business Development. At Microsoft, his team creates partnerships that help enable the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. With advanced technologies that include intelligent cloud and intelligent edge services, Microsoft enables business outcomes that include: transforming products, optimizing operations, empowering employees, and enhancing customer engagement. Prior to joining Microsoft in 1996, Mr. Dallas held roles at NVIDIA Corporation and National Semiconductor (now Texas Instruments Inc.) in the U.S., Europe and the Middle East in roles that included microprocessor design, systems engineering, product management, and end-to-end business leadership. He holds an Executive M.B.A. from the Kellogg School of Management at Northwestern University, and a B.S. degree in Computer Science from Staffordshire University, Stoke-on-Trent, Staffordshire, England.

Joseph Lacob

Mr. Joseph S. Lacob is Independent Director of the Company. In 2011, Mr. Lacob acquired The Golden State Warriors of the National Basketball Association. He is currently the Managing Partner and CEO of the Warriors. Prior to joining KPCB in 1987, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization, and the management consulting firm of Booz, Allen & Hamilton. He was previously on the board of directors of Orexigen Therapeutics, a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Mr. Lacob received his B.S. in Biological Sciences from the University of California at Irvine, his Masters in Public Health from the University of California at Los Angeles and his M.B.A. from Stanford University.

George Morrow

Mr. George J. Morrow is Independent Director of the Company. From February 2011 until January 2013, Mr. Morrow served as a consultant to Amgen Inc., a global biotechnology company. From 2003 until his retirement in February 2011, he was the Executive Vice President, Global Commercial Operations at Amgen Inc., where he also served as Executive Vice President of Worldwide Sales and Marketing between 2001 and 2003. From 1992 to 2001, Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc. He is a member of the board of directors of Vical Incorporated, a company that researches and develops biopharmaceutical products, Otonomy, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the inner and middle ear and Neurocrine Biosciences, a biotechnology company focused on neurologic, psychiatric and endocrine related disorders. He was on the board of Safeway Inc., a food and drug retailer from May 2013 until February 2015. Mr. Morrow holds a B.S. in Chemistry from Southampton College, Long Island University, an M.S. in Biochemistry from Bryn Mawr College and an M.B.A. from Duke University.

Andrea Saia

Ms. Andrea L. Saia is Independent Director of the Company. Ms. Saia was previously the Global Head of Vision Care in the Alcon division of Novartis AG, from 2011 until her retirement in 2012. Prior to this role, she served as President and Chief Executive Officer of CibaVision Corporation, a subsidiary of Novartis, from 2008 to 2011. From 2005 to 2007, she relocated to Switzerland and served as President of Europe, Middle East, and Africa operations, CibaVision’s largest regional business unit. She initially joined CibaVision in 2002 as Global Head of Marketing and was promoted to President of the Global Lens Business the following year. Prior to Novartis, Ms. Saia was the Chief Marketing Officer for GCG Partners Inc. Ms. Saia also held senior management and marketing positions with global consumer products companies such as Procter & Gamble Co., Unilever, and Revlon, Inc. Ms. Saia earned an M.B.A. from J.L. Kellogg Graduate School of Management and a B.S. in Business Administration from Miami University. Ms. Saia also served on the board of directors of Coca-Cola Enterprises, Inc., the marketer, producer and distributor of Coca-Cola products in European markets from 2012 to 2016. Since July 2016, Ms. Saia has also served on the board of directors of LivaNova PLC, a global medical technology company.

Gregory Santora

Mr. Gregory J. Santora is Independent Director of the Company. Mr. Santora served as Chief Financial Officer at Shopping.com, a provider of internet-based comparison shopping resources, from December 2003 until September 2005. From 1997 through 2002, he served as Senior Vice President and Chief Financial Officer for Intuit, Inc., a provider of small business and personal finance software. Prior to Intuit, Mr. Santora spent nearly 13 years at Apple Computer in various senior financial positions including Senior Finance Director of Apple Americas and Senior Director of Internal Consulting and Audit. Mr. Santora, who began his accounting career with Arthur Andersen L.L.P., has been a CPA since 1974. He served on the board of directors of RetailMeNot, Inc., a digital coupon site, from May 2013 until its sale in May 2017. Mr. Santora holds a B.S. in Accounting from the University of Illinois and an M.B.A. from San Jose University.

Susan Siegel

Ms. Susan E. Siegel serves as Independent Director of the Company. In November 2017, she was appointed Chief Innovation Officer at General Electric and Chief Executive Officer of GE Business Innovations, GE's growth and innovation business. Since 2012, she has been Chief Executive Officer of GE Ventures, now subsumed into her new role. Prior to joining GE, from May 2006 to May 2012, she was a General Partner at Mohr Davidow Ventures, where she led healthcare and lifescience investments. From April 1998 to April 2006, Ms. Siegel was at Affymetrix, Inc. where she served as President and as a member of the board of directors. Ms. Siegel holds a B.S. in Biology from the University of Puerto Rico and a M.S. in Biochemistry and Molecular Biology from Boston University Medical School.

Warren Thaler

Mr. Warren S. Thaler is Independent Director of the Company. Since July 2017, Mr. Thaler has been a consultant to Gund Investment Corporation, an investment firm owned by Gordon Gund with holdings in real estate and private equity securities. Prior to acting as a consultant for Gund Investment Corporation, Mr. Thaler served as its president. Since 1990, Mr. Thaler has served on the board of directors of several privately held companies owned by the Gund family. From 1990 to 2005, Mr. Thaler was on the board of directors of the Cleveland Cavaliers and Gund Arena Company and from 2001 to 2005 represented the Cleveland Cavaliers as its Alternate Governor at meetings of the National Basketball Association’s Board of Governors. Mr. Thaler received his B.A. from Princeton University and his M.B.A. from Harvard University.

Shirley Stacy